10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
PFIZER INC | |||
Ticker: PFE Fiscal Year: 2022 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2022 10-K (Filed: Feb 23, 2023) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
| Operating Activities | |||
| Net income before allocation to noncontrolling interests | $ 31,407 | 22,025 | 9,195 |
| Discontinued operationsnet of tax | 6 | (434) | 2,529 |
| Net income from continuing operations before allocation to noncontrolling interests | 31,401 | 22,459 | 6,666 |
| Adjustments to reconcile net income before allocation to noncontrolling interests to net cash provided by operating activities: | |||
| Depreciation and amortization | 5,064 | 5,191 | 4,681 |
| Asset write-offs and impairments | 550 | 276 | 2,049 |
| Deferred taxes from continuing operations | (3,764) | (4,293) | (1,575) |
| Share-based compensation expense | 872 | 1,182 | 755 |
| Benefit plan contributions in excess of expense/income | (1,158) | (3,123) | (1,242) |
| Other adjustments, net | 758 | (1,573) | (485) |
| Other changes in assets and liabilities, net of acquisitions and divestitures: | |||
| Trade accounts receivable | 261 | (3,811) | (1,275) |
| Inventories | 592 | (1,125) | (778) |
| Other assets | (4,506) | (1,057) | (137) [1] |
| Trade accounts payable | 1,191 | 1,242 | 355 |
| Other liabilities | (1,449) | 18,721 | 2,768 |
| Other tax accounts, net | (545) | (1,166) | (1,240) |
| Net cash provided by operating activities from continuing operations | 29,267 | 32,922 | 10,540 |
| Net cash provided by/(used in) operating activities from discontinued operations | 0 | (343) | 3,863 |
| Net cash provided by operating activities | 29,267 | 32,580 | 14,403 |
| Investing Activities | |||
| Purchases of property, plant and equipment | (3,236) | (2,711) | (2,226) |
| Purchases of short-term investments | (36,384) | (38,457) | (13,805) |
| Proceeds from redemptions/sales of short-term investments | 44,821 | 27,447 | 11,087 |
| Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less | (483) | (8,088) | 920 |
| Purchases of long-term investments | (1,913) | (1,068) | (597) |
| Proceeds from redemptions/sales of long-term investments | 641 | 649 | 723 |
| Acquisitions of businesses, net of cash acquired | (22,997) | 0 | 0 |
| Dividend received from the Consumer Healthcare JV | 3,960 [2] | 0 | 0 |
| Other investing activities, net | (192) | (305) | (265) |
| Net cash provided by/(used in) investing activities from continuing operations | (15,783) | (22,534) | (4,162) |
| Net cash provided by/(used in) investing activities from discontinued operations | 0 | (12) | (109) |
| Net cash provided by/(used in) investing activities | (15,783) | (22,546) | (4,271) |
| Financing Activities | |||
| Proceeds from short-term borrowings | 3,891 | 0 | 12,352 |
| Payments on short-term borrowings | (3,887) | 0 | (22,197) |
| Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less | (222) | (96) | (4,129) |
| Proceeds from issuances of long-term debt | 0 | 997 | 5,222 |
| Payments on long-term debt | (3,298) | (2,004) | (4,003) |
| Purchases of common stock | (2,000) | 0 | 0 |
| Cash dividends paid | (8,983) | (8,729) | (8,440) |
| Other financing activities, net | (335) | 16 | (444) |
| Net cash provided by/(used in) financing activities from continuing operations | (14,834) | (9,816) | (21,640) |
| Net cash provided by/(used in) financing activities from discontinued operations | 0 | 0 | 11,991 |
| Net cash provided by/(used in) financing activities | (14,834) | (9,816) | (9,649) |
| Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents | (165) | (59) | (8) |
| Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents | (1,515) | 159 | 475 |
| Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period | 1,983 | 1,825 | |
| Cash and cash equivalents and restricted cash and cash equivalents, at end of period | 468 | 1,983 | 1,825 |
| Supplemental Cash Flow Information | |||
| Cash paid/(received) during the period for: | |||
| Income taxes | 7,867 | 7,427 | 3,153 |
| Interest paid | 1,442 | 1,467 | 1,641 |
| Interest rate hedges | 54 | (2) | (20) |
| Non-cash transaction: | |||
| Right-of-use assets obtained in exchange for lease liabilities | 752 | 1,943 | 410 |
| [1] See Note 8A. | |||
| [2] See Note 2C. | |||
| External Links | |
| PFIZER INC (PFE) Fiscal Year 2022 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |